Quick Takeaways
- This page summarizes Judith Fran Marks's Form 4 filing for Otis Worldwide Corp (OTIS).
- 11 reported transactions and 3 derivative rows are listed below.
- Filing timestamp: 05 Feb 2026, 19:49.
Quoteable Key Fact
"Judith Fran Marks filed Form 4 for Otis Worldwide Corp (OTIS) on 05 Feb 2026."
| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Marks Judith Fran | Chair, CEO and President, Director | 1 CARRIER PLACE, FARMINGTON | Susan Grady, Attorney-in-Fact | 05 Feb 2026 | 0001665490 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OTIS | Common Stock | Award | +58,169 | +26% | 279,781 | 03 Feb 2026 | Direct | F5 | ||
| transaction | OTIS | Common Stock | Tax liability | $1,052,283 | -12,073 | -4.3% | $87.16 | 267,708 | 03 Feb 2026 | Direct | |
| transaction | OTIS | Common Stock | Options Exercise | +18,425 | +6.9% | 286,133 | 04 Feb 2026 | Direct | F1 | ||
| transaction | OTIS | Common Stock | Tax liability | $748,354 | -8,281 | -2.9% | $90.37 | 277,852 | 04 Feb 2026 | Direct | |
| transaction | OTIS | Common Stock | Sale | $4,190,057 | -46,780 | -17% | $89.57 | 231,072 | 04 Feb 2026 | Direct | F6 |
| transaction | OTIS | Common Stock | Options Exercise | $12,259,792 | +191,799 | +83% | $63.92 | 422,871 | 04 Feb 2026 | Direct | F4 |
| transaction | OTIS | Common Stock | Disposed to Issuer | $12,259,772 | -135,692 | -32% | $90.35 | 287,179 | 04 Feb 2026 | Direct | |
| transaction | OTIS | Common Stock | Sale | $5,099,352 | -56,107 | -20% | $90.89 | 231,072 | 05 Feb 2026 | Direct | F7, F8 |
| holding | OTIS | Common Stock | 23,000 | 03 Feb 2026 | by 2025 GRAT | F9 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OTIS | Restricted Stock Units | Award | $0 | +59,305 | $0.000000 | 59,305 | 03 Feb 2026 | Common Stock | 59,305 | Direct | F1, F2 | ||
| transaction | OTIS | Restricted Stock Units | Options Exercise | $0 | -18,425 | -33% | $0.000000 | 36,862 | 04 Feb 2026 | Common Stock | 18,425 | Direct | F1, F3 | |
| transaction | OTIS | Stock Appreciation Rights | Options Exercise | $0 | -191,799 | -100% | $0.000000 | 0 | 04 Feb 2026 | Common Stock | 191,799 | $63.92 | Direct | F4 |
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
| Id | Content |
|---|---|
| F1 | Restricted stock units (RSUs) convert into common stock on a one-for-one basis. RSUs include the right to receive dividend equivalents that are credited as additional RSUs. |
| F2 | RSUs vest in three substantially equal annual installments beginning on the first anniversary of the Transaction Date. |
| F3 | On February 4, 2025, the reporting person was granted RSUs vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. The first installment vested on the Transaction Date. |
| F4 | This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2025. |
| F5 | The acquisition of Otis common stock represents the vesting of performance share units (PSUs) previously awarded on February 7, 2023. Each PSU has a value equal to one share of Otis common stock. These PSUs vested on the Transaction Date upon the achievement of the 3-year cycle preestablished performance targets. The performance criteria were certified to be achieved at the 82% level. The reporting person previously elected to defer 50% of this award under the LTIP PSU Deferral Plan upon vesting. Any vested shares that are deferred under this plan are credited as DSUs and will be settled in stock. The DSUs will be paid out in an equal number of shares of Otis common stock in accordance with the reporting person's previous elections. DSUs accrue dividend equivalents. |
| F6 | This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2025. The shares sold in multiple trades at prices ranging from $87.73 to $90.45. The price reported above reflects the weighted average sale price. The reporting person undertakes to provide the registrant, any security holder of the registrant, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. The number of shares sold includes the shares received by the reporting person upon the vesting of the PSUs previously awarded on February 7, 2023 after giving effect to the tax withholdings and the 50% PSU deferral election. |
| F7 | This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2025. The shares sold in multiple trades at prices ranging from $89.755 to $91.495. The price reported above reflects the weighted average sale price. The reporting person undertakes to provide the registrant, any security holder of the registrant, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| F8 | Includes (i) 12,800 shares previously held through the 2023 grantor retained annuity trust (GRAT) which were transferred to the reporting person on August 25, 2025 and are now owned directly and (ii) 1,658 dividend equivalents issued on DSU's under the LTIP PSU Deferral Plan since March 2025. |
| F9 | The reporting person established a GRAT on September 5, 2025 and contributed 23,000 shares of the Issuer's common stock to it on September 10, 2025. The reporting person is the sole trustee and annuitant of the GRAT, which is scheduled to expire in accordance with its terms on September 10, 2027. |
Exhibit List: Exhibit 24 - Power of Attorney. This form includes transactions effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 25, 2025. The plan will terminate on March 1, 2026.